Soligenix, Inc. News, Soligenix, Inc. Quote, SNGX Quote

Soligenix, Inc. (NQ:SNGX) Delayed: 0.41 +0.03 (7.89%)

Prev. Close

$0.38

Open

$0.38

52 Wk High

$4.35

52 Wk Low

$0.44

Day High

$0.44

Day Low

$0.38

P/E

N/A

EPS

$-0.81

Volume

544,775

Friends, Peers and Foes (?): MOB, GENE, BIVI, 0A6I, DOA2 (more...)

Apr 25, 2024 07:30 AM Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
Apr 22, 2024 04:07 PM Form 8-K SOLIGENIX, INC. For: Apr 17
Apr 19, 2024 04:31 PM Form PRE 14A SOLIGENIX, INC. For: May 23
Apr 19, 2024 04:06 PM Form 424B4 SOLIGENIX, INC.
Apr 18, 2024 08:30 AM Soligenix, Inc. (SNGX) Prices $4.75 Million Public Offering
Apr 18, 2024 08:30 AM Soligenix Announces Pricing of $4.75 Million Public Offering
Apr 17, 2024 06:04 AM Form EFFECT SOLIGENIX, INC.
Apr 15, 2024 07:30 AM Soligenix, Inc. (SNGX) Announces FDA Grants Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Apr 15, 2024 07:30 AM FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Apr 11, 2024 07:32 AM Soligenix (SNGX) Granted FDA Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

Entities mentioned with SNGX